enow.com Web Search

  1. Ad

    related to: genentech ophthalmology pipeline hospital beds available

Search results

  1. Results from the WOW.Com Content Network
  2. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]

  3. Category:Drugs developed by Genentech - Wikipedia

    en.wikipedia.org/wiki/Category:Drugs_developed...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more

  4. Cabilly patents - Wikipedia

    en.wikipedia.org/wiki/Cabilly_patents

    An interference between U.S. patent 4,816,567 (the original "Cabilly patent") co-issued to Genentech and City of Hope and U.S. patent 4,816,397 (the "Boss" patent) issued to Celltech resulted in the issuance of a second "Cabilly patent" to Genentech in 2001. This new patent would extend into 2018, an effective term of 29 years.

  5. Genentech to Present Important New Data Reflecting Broad ...

    www.aol.com/news/2013-05-15-genentech-to-present...

    The Roche/Genentech oncology pipeline includes 40 investigational cancer medicines being studied in 600 clinical trials across a dozen types of cancer.

  6. Etrolizumab - Wikipedia

    en.wikipedia.org/wiki/Etrolizumab

    Etrolizumab was developed by Genentech [2] [3] by engineering the FIB504 antibody to include human IgGl-heavy chain and κ-light chain frameworks; it is manufactured in CHO cells. [4] As of 2016, it was in phase III studies for induction and maintenance therapy in people with ulcerative colitis and Crohn's.

  7. Category:Genentech - Wikipedia

    en.wikipedia.org/wiki/Category:Genentech

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more

  8. Pieris Stock Surges on Development Pact with Genentech ... - AOL

    www.aol.com/news/pieris-stock-surges-development...

    Genentech will also have the option to select additional targets in return for an option exercise fee. Price Action: PIRS shares are up 49.3% at $2.76 on the last check Tuesday.

  9. Bascom Palmer Eye Institute - Wikipedia

    en.wikipedia.org/wiki/Bascom_Palmer_Eye_Institute

    Ophthalmology at the University of Miami School of Medicine began in 1955 and attained departmental status in 1959. [3]Bascom Palmer Eye Institute was founded seven years later, on January 20, 1962, by Edward W. D. Norton, a neuro-ophthalmologist, retinal specialist, administrator and professor who joined the University of Miami's School of Medicine with aspirations of building a regional ...

  1. Ad

    related to: genentech ophthalmology pipeline hospital beds available